BIOMAT Database Logo BIOMAT Database Logo

Fluspirilene in the treatment of chronic schizophrenic patients. 1970

G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001555 Benzene Derivatives Organic compounds derived from BENZENE. Derivatives, Benzene
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013141 Spiro Compounds Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie. Compounds, Spiro
D014149 Tranquilizing Agents A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. Ataractics,Tranquilizing Drugs,Tranquilizing Effect,Tranquilizing Effects,Tranquillizing Agents,Tranquillizing Drugs,Agents, Tranquilizing,Agents, Tranquillizing,Drugs, Tranquilizing,Drugs, Tranquillizing,Effect, Tranquilizing,Effects, Tranquilizing

Related Publications

G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Fluspirilene in the treatment of chronic schizophrenic outpatients.
September 1972, Current therapeutic research, clinical and experimental,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Fluspirilene in the treatment of non-hospitalized schizophrenic patients.
January 1977, Current medical research and opinion,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients.
October 1973, Canadian Psychiatric Association journal,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
[Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
January 1973, International pharmacopsychiatry,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
January 1973, The Journal of clinical pharmacology and new drugs,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
January 1974, Acta psychiatrica Scandinavica. Supplementum,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
January 1971, Acta psychiatrica Scandinavica,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Treatment of chronic schizophrenic patients.
August 1988, Journal of clinical psychopharmacology,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Protrptyline in the treatment of chronic schizophrenic patients.
March 1970, Current therapeutic research, clinical and experimental,
G Chouinard, and T A Ban, and H E Lehmann, and J V Ananth
Ambulatory activity during treatment with fluspirilene in chronic schizophrenics.
January 1974, Acta psychiatrica Scandinavica. Supplementum,
Copied contents to your clipboard!